Literature DB >> 16403402

Acute myeloid leukemia clinical practice guidelines in oncology.

Margaret R O'Donnell1, Frederick R Appelbaum, Maria R Baer, John C Byrd, Steven E Coutre, Lloyd E Damon, Harry P Erba, Eli Estey, James Foran, Jeffrey Lancet, Lori J Maness, Peter G Maslak, Michael Millenson, Joseph O Moore, Donna Przepiorka, Paul Shami, B Douglas Smith, Richard M Stone, Martin S Tallman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16403402     DOI： 10.6004/jnccn.2006.0004

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  4 in total

1.  Potential clinical impact of three-dimensional visualization for fluorescent in situ hybridization image analysis.

Authors:  Zheng Li; Shibo Li; Zheng Bin; Roy Zhang; Yuhua Li; Huimin Tian; Wei Chen; Hong Liu
Journal:  J Biomed Opt       Date:  2012-05       Impact factor: 3.170

2.  Challenges in treating older patients with acute myeloid leukemia.

Authors:  Lagadinou D Eleni; Zoumbos C Nicholas; Spyridonidis Alexandros
Journal:  J Oncol       Date:  2010-06-10       Impact factor: 4.375

3.  Metronomic therapy with oral 6-mercaptopurine in elderly acute myeloid leukemia: A prospective pilot study.

Authors:  Akhil Kapoor; Surender Kumar Beniwal; Ashok Kalwar; Mukesh Kumar Singhal; Raj Kumar Nirban; Harvindra Singh Kumar
Journal:  South Asian J Cancer       Date:  2016 Apr-Jun

4.  Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.

Authors:  Haibo Sun; De-Chen Lin; Xiao Guo; Behzad Kharabi Masouleh; Sigal Gery; Qi Cao; Serhan Alkan; Takayuki Ikezoe; Chie Akiba; Ronald Paquette; Wenwen Chien; Carsten Müller-Tidow; Yang Jing; Konstantin Agelopoulos; Markus Müschen; H Phillip Koeffler
Journal:  Oncotarget       Date:  2016-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.